Atropine 0.01% Eyedrops for Evolutive Myopia Treatment in Children

  • STATUS
    Recruiting
  • End date
    Dec 28, 2027
  • participants needed
    50
  • sponsor
    Centre Hospitalier Universitaire de Saint Etienne
Send
Updated on 19 February 2024
See if I qualify
atropine
ophthalmic solution
myopia

Summary

Prevalence of myopia and its complications has been increasing over the past decades, especially among children and adolescents. It reaches record levels in Asia: nearly 80% of the population in some regions in 2012 where the investigators speak in terms of epidemic.

ATROPINE 0.01% eyedrops one drop per day is today an evolutive myopia treatment, whose results are promising.

The investigators use this eye drops in our clinical practice at hospital of Saint-Etienne since 2017.

Few clinical data have been published so far concerning the French population.

The investigators would like to build a database so that the investigators can publish our results and share our experience.

Details
Condition Child, Myopia, Myopia
Age 18years or below
Treatment data collection
Clinical Study IdentifierNCT04252989
SponsorCentre Hospitalier Universitaire de Saint Etienne
Last Modified on19 February 2024

Eligibility

 Yes No Not Sure

Inclusion Criteria

Children with active myopia treated with ATROPINE 0.01% eye drops
patient affiliated with a social security organization
agreement of both parents

Exclusion Criteria

non compliance with treatment
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

atropine
ophthalmic solution
myopia

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.